[Cell-mediated immunity in patients with oral cancer. II: Correlation of peripheral lymphocyte reactivity with the clinical course].
D006801:Humans; D007111:Immunity, Cellular; D008213:Lymphocyte Activation / Q000187:drug effects; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology*; D008934:Mitogens / Q000494:pharmacology; D009062:Mouth Neoplasms / Q000276:immunology*; D010835:Phytohemagglutinins / Q000494:pharmacology; D011379:Prognosis
D008934:Mitogens; D010835:Phytohemagglutinins